[ {
  "@graph" : [ {
    "@id" : "http://www.tkuhn.ch/bel2nanopub/RAfTPeV-HrPsC4lIiKIutJaOv1NsIFgnqihdAN1u0mxJA",
    "@type" : [ "http://www.nanopub.org/nschema#Nanopublication" ],
    "http://www.nanopub.org/nschema#hasAssertion" : [ {
      "@id" : "http://www.tkuhn.ch/bel2nanopub/RAfTPeV-HrPsC4lIiKIutJaOv1NsIFgnqihdAN1u0mxJA#assertion"
    } ],
    "http://www.nanopub.org/nschema#hasProvenance" : [ {
      "@id" : "http://www.tkuhn.ch/bel2nanopub/RAfTPeV-HrPsC4lIiKIutJaOv1NsIFgnqihdAN1u0mxJA#provenance"
    } ],
    "http://www.nanopub.org/nschema#hasPublicationInfo" : [ {
      "@id" : "http://www.tkuhn.ch/bel2nanopub/RAfTPeV-HrPsC4lIiKIutJaOv1NsIFgnqihdAN1u0mxJA#pubinfo"
    } ]
  } ],
  "@id" : "http://www.tkuhn.ch/bel2nanopub/RAfTPeV-HrPsC4lIiKIutJaOv1NsIFgnqihdAN1u0mxJA#Head"
}, {
  "@graph" : [ {
    "@id" : "http://www.tkuhn.ch/bel2nanopub/RAfTPeV-HrPsC4lIiKIutJaOv1NsIFgnqihdAN1u0mxJA#_1",
    "@type" : [ "http://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI_36080" ],
    "http://purl.obolibrary.org/obo/RO_0002204" : [ {
      "@id" : "http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=19391"
    } ]
  }, {
    "@id" : "http://www.tkuhn.ch/bel2nanopub/RAfTPeV-HrPsC4lIiKIutJaOv1NsIFgnqihdAN1u0mxJA#_2",
    "@type" : [ "http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement" ],
    "http://purl.obolibrary.org/obo/BFO_0000066" : [ {
      "@id" : "http://www.lgcstandards-atcc.org/Products/All/HTB-22.aspx"
    }, {
      "@id" : "http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?id=9606"
    } ],
    "http://www.w3.org/1999/02/22-rdf-syntax-ns#object" : [ {
      "@id" : "http://resource.belframework.org/belframework/1.0/namespace/selventa-legacy-chemical-names/cytokine"
    } ],
    "http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate" : [ {
      "@id" : "http://www.selventa.com/vocabulary/decreases"
    } ],
    "http://www.w3.org/1999/02/22-rdf-syntax-ns#subject" : [ {
      "@id" : "http://www.tkuhn.ch/bel2nanopub/RAfTPeV-HrPsC4lIiKIutJaOv1NsIFgnqihdAN1u0mxJA#_1"
    } ]
  }, {
    "@id" : "http://www.tkuhn.ch/bel2nanopub/RAfTPeV-HrPsC4lIiKIutJaOv1NsIFgnqihdAN1u0mxJA#assertion",
    "http://www.w3.org/2000/01/rdf-schema#label" : [ {
      "@value" : "p(HGNC:SOCS3) -| a(SCHEM:cytokine)"
    } ]
  } ],
  "@id" : "http://www.tkuhn.ch/bel2nanopub/RAfTPeV-HrPsC4lIiKIutJaOv1NsIFgnqihdAN1u0mxJA#assertion"
}, {
  "@graph" : [ {
    "@id" : "http://resource.belframework.org/belframework/1.0/knowledge/large_corpus.bel",
    "http://purl.org/dc/elements/1.1/description" : [ {
      "@value" : "Approximately 61,000 statements."
    } ],
    "http://purl.org/dc/elements/1.1/rights" : [ {
      "@value" : "Copyright (c) 2011-2012, Selventa. All rights reserved."
    } ],
    "http://purl.org/dc/elements/1.1/title" : [ {
      "@value" : "BEL Framework Large Corpus Document"
    } ],
    "http://purl.org/pav/authoredBy" : [ {
      "@id" : "http://www.tkuhn.ch/bel2nanopub/RAfTPeV-HrPsC4lIiKIutJaOv1NsIFgnqihdAN1u0mxJA#_4"
    } ],
    "http://purl.org/pav/version" : [ {
      "@value" : "1.4"
    } ]
  }, {
    "@id" : "http://www.tkuhn.ch/bel2nanopub/RAfTPeV-HrPsC4lIiKIutJaOv1NsIFgnqihdAN1u0mxJA#_3",
    "http://www.w3.org/ns/prov#value" : [ {
      "@value" : "The suppressor of cytokine signalling (SOCS) protein family negatively regulates cytokine action. In this study, we investigated the effects of estrogen (E2) on SOCS-3 expression in T47D and MCF-7 human breast cancer cells. Real-time PCR analysis of E2-treated T47D cells revealed a ligand and time-dependent increase in of SOCS-3 mRNA levels. Cloning of a 1.7 kb fragment of the human SOCS-3 5' flanking sequence, and subsequent analysis of potential transcription factor-binding sites identified an incomplete ERE motif located -1493 to -1489 upstream of the start site. Transient transfection of the cloned fragment in MCF-7 cells showed that both E2 and genistein treatment caused an increase in reporter gene activity, which was inhibited by co-treatment with ICI 182,780. Chromatin immunoprecipitation analysis revealed an E2 and time-dependent recruitment of ERalpha to the E2 responsive region of the human SOCS-3 promoter. In summary, this study shows that ERalpha directly regulates human SOCS-3 promoter activity in human breast cancer cells, thus modulating cytokine activity."
    } ],
    "http://www.w3.org/ns/prov#wasQuotedFrom" : [ {
      "@id" : "http://www.ncbi.nlm.nih.gov/pubmed/16055089"
    } ]
  }, {
    "@id" : "http://www.tkuhn.ch/bel2nanopub/RAfTPeV-HrPsC4lIiKIutJaOv1NsIFgnqihdAN1u0mxJA#_4",
    "http://www.w3.org/2000/01/rdf-schema#label" : [ {
      "@value" : "Selventa"
    } ]
  }, {
    "@id" : "http://www.tkuhn.ch/bel2nanopub/RAfTPeV-HrPsC4lIiKIutJaOv1NsIFgnqihdAN1u0mxJA#assertion",
    "http://www.w3.org/ns/prov#hadPrimarySource" : [ {
      "@id" : "http://www.ncbi.nlm.nih.gov/pubmed/16055089"
    } ],
    "http://www.w3.org/ns/prov#wasDerivedFrom" : [ {
      "@id" : "http://resource.belframework.org/belframework/1.0/knowledge/large_corpus.bel"
    }, {
      "@id" : "http://www.tkuhn.ch/bel2nanopub/RAfTPeV-HrPsC4lIiKIutJaOv1NsIFgnqihdAN1u0mxJA#_3"
    } ]
  } ],
  "@id" : "http://www.tkuhn.ch/bel2nanopub/RAfTPeV-HrPsC4lIiKIutJaOv1NsIFgnqihdAN1u0mxJA#provenance"
}, {
  "@graph" : [ {
    "@id" : "http://www.tkuhn.ch/bel2nanopub/RAfTPeV-HrPsC4lIiKIutJaOv1NsIFgnqihdAN1u0mxJA",
    "http://purl.org/dc/terms/created" : [ {
      "@type" : "http://www.w3.org/2001/XMLSchema#dateTime",
      "@value" : "2014-07-03T14:30:37.040+02:00"
    } ],
    "http://purl.org/pav/createdBy" : [ {
      "@id" : "http://orcid.org/0000-0001-6818-334X"
    }, {
      "@id" : "http://orcid.org/0000-0002-1267-0234"
    } ]
  } ],
  "@id" : "http://www.tkuhn.ch/bel2nanopub/RAfTPeV-HrPsC4lIiKIutJaOv1NsIFgnqihdAN1u0mxJA#pubinfo"
} ]